UNSPSC 51152054: Decamethonium bromide

This classification denotes a muscle relaxant with the molecular formula C16H38N2.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 55C6RK944K, chemically known as 1,10-decanediaminium, n,n,n,n,n,n-hexamethyl-, monobromide but more generally known as decamethonium bromide, which bears US NIH Compound Identifier 2968. European Medicines Agency schedules Decamethonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06930MIG.

UNSPSC 51152054 Decamethonium bromide is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—is for naloxone and safe drug deactivation systems, not decamethonium bromide, suggesting a tagging mismatch rather than authentic procurement under the code's intended product category. Decamethonium bromide is a neuromuscular blocking agent with specialized pharmaceutical applications; the Seminole County solicitation targets community health opioid-response supplies. State and local governments do not appear to be sourcing decamethonium bromide through open procurement notices at this time.

Seminole County, a Florida county government health department, issued the only recent opportunity captured under this code. The IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The mismatch between the code assignment and the actual solicitation content indicates that this Commodity code does not reflect active state and local purchasing for decamethonium bromide or related pharmaceutical agents in the current market.